可应用于导航手术的三维酰胺质子转移(APT)成像能呈现与11C-甲硫氨酸PET相当的胶质母细胞瘤代谢活性
本研究纳入26例连续胶质母细胞瘤患者,其中10例接受11C-甲硫氨酸PET检查,全部26例接受二维APT采集,最近14例接受三维快速自旋回波APT成像并整合导航系统。三维APT与二维APT视觉上几乎等效,其对肿瘤浸润区域的判定与11C-Met-PET相似,作者认为三维APT可能作为替代11C-Met-PET的影像模态。
要点
- 三维APT成像与二维APT在胶质母细胞瘤中视觉上几乎等效,平均APT强度几乎相等
- 三维APT判断肿瘤浸润边界的APTmean最佳截断值为1.28%,敏感度和特异度均为100%
- 三维APT可整合入导航系统,作者认为其可能替代11C-Met-PET用于胶质母细胞瘤手术
核心结论
- 三维APT可类似11C-Met-PET评估肿瘤浸润区域,判定浸润肿瘤细胞区与几乎无肿瘤细胞区边界的截断值为12.8%。
- 三维APT可应用于导航系统,作者认为其可能作为替代11C-Met-PET的影像模态用于胶质母细胞瘤手术。
研究设计与样本
- 本研究纳入26例连续胶质母细胞瘤患者,其中10例接受11C-Met-PET检查。
- 全部26例接受二维单次激发快速自旋回波APT采集,最近14例接受三维快速自旋回波APT成像以评估其能否应用于导航系统。
主要发现
- 三维APT在视觉上与二维APT几乎等效,三维APT获得的胶质母细胞瘤平均APT强度与二维APT几乎相等。
- 在11C-Met-PET肿瘤/对侧正常脑组织比值(TNR)为1.4的部位,二维APT的平均APTmean为1.52±0.16%,三维APT在同一部位的平均APTmean为1.30±0.06%。
- 三维APT的APTmean最佳截断值为1.28%,敏感度100%、特异度100%。
- 平均APTmean为1.28%区域的平均Ki-67染色指数为11.8%(范围5.0-20.0%)。
关键数值与推荐
- 三维APT判定浸润肿瘤细胞区与几乎无肿瘤细胞区边界的APTmean截断值为1.28%,结论中表述为12.8%。
临床怎么用
- 将三维APT整合入导航系统后,可在影像引导导航下切除包括浸润肿瘤细胞在内的肿瘤。
- 作者认为三维APT可能作为替代11C-Met-PET的影像模态用于胶质母细胞瘤手术。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Amide proton transfer (APT) imaging has been proposed as a technique to assess tumor metabolic activity. We have previously 11C-methionine positron emission tomography (11C-Met-PET) can evaluate the metabolic activity of peritumoral area including infiltrating tumor cells in glioblastoma (GBM). To resolve disadvantages of 11C-Met-PET, in the present study, we aimed to evaluate whether three-dimensional fast spin echo-based APT (3D FSE-APT) imaging is usable for not only presenting the metabolic activity of brain tumors, but also detecting areas where infiltrating tumor cells including glioma stem cells (GSCs) could exist, by applying an image-guided navigation system incorporating 3D FSE-APT to glioblastoma surgery. METHODS: Twenty-six consecutive patients with GBMs were enrolled in this study. Among these 26 cases, 10 patients underwent 11C-Met-PET examination. All 26 patients underwent two-dimensional single shot fast spine echo-based APT acquisition with a chemical exchange saturation transfer sequence (2D SSFSE-APT). The most recent 14 cases underwent 3D FSE-APT to examine whether 3D APT imaging was applicable to the navigation system. We investigated the clinical applicability of 3D FSE-APT by comparison with 2D SSFSE-APT and evaluated the utility of 3D FSE-APT as a metabolic imaging guide in the intraoperative navigation system. We also analyzed whether 3D FSE-APT can depict the extent of infiltrating tumor cells including GSCs in the peritumoral area in GBM. RESULTS: The most recent 14 cases underwent 3D FSE-APT. The 3D FSE-APT was visually almost equivalent to 2D SSFSE-APT and mean APT intensity (APTmean) in GBM obtained by 3D FSE-APT was almost equal to that from 2D SSFSE-APT. Mean APTmean on 2D SSFSE-APT at the site showing a tumor-to-contralateral normal brain tissue ratio (TNR) of 1.4 on 11C-Met-PET was 1.52 ± 0.16%. In contrast, mean APTmean on 3D FSE-APT at the same site was 1.30 ± 0.06%. The optimal cut-off value for APTmean on 3D FSE-APT was evaluated as 1.28%, offering 100% sensitivity and 100% specificity. Incorporating 3D FSE-APT into the navigation system allowed tumor resection including infiltrating tumor cells under image-guided navigation. Mean Ki-67 staining index in the area with a mean APTmean of 1.28% was 11.8% (range, 5.0-20.0%). CONCLUSIONS: The area of tumor invasion could be evaluated by 3D FSE-APT in a similar way to 11C-Met-PET, and the cut-off value for deciding the borderline between the area including infiltrating tumor cells and that with almost no tumor cells was 12.8%. In addition, 3D FSE-APT could be applied to navigation systems and may have great potential as an imaging modality replacing 11C-Met-PET in GBM surgery.
引用
- Inoue A, Watanabe H, Kusakabe K, et al. Three-dimensional amide proton transfer (APT) imaging appliable to navigation surgery can present comparable metabolic activity of glioblastoma to 11C-Methionine PET. Acta Neurochir (Wien). 2025. PMID: 39969596. doi:10.1007/s00701-025-06465-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。